News
Continuous glucose monitoring provides a new, less invasive method for evaluating diabetes risk. Fluctuations in blood ...
23h
Medical Device Network on MSNGlucotrack gains HREC approval for clinical study of CBGM deviceGlucotrack has announced the receipt of St Vincent’s Hospital Melbourne HREC approval for a CBGM study for types 1 and 2 ...
7d
Interesting Engineering on MSNNew wearable tech detects diabetes risk early, eliminates need for needle pricksContinuous glucose monitoring can now spot early diabetes risks, offering a non-invasive alternative to traditional blood ...
I wore Dexcom’s over-the-counter blood glucose monitor for a month. Here’s how it compares to Lingo and what it’s like to use ...
The Swiss biotech company Roche on Monday announced plans for a $550 million expansion of its Indianapolis diagnostics and ...
Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...
CCS has saved more than $10 million in taxpayer dollars through the use of PropheSee, its predictive analytics platform, ...
StockStory.org on MSN10h
Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The RestQuarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis ...
Long-term clinical evaluation represents key advancement following successful first-in-human studyRUTHERFORD, N.J., May 13, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or ...
How wearables are reshaping chronic disease management with real-time data, personalized treatment, and early intervention ...
Both Meal and Glucose are now available to Oura members on iOS and Android in the US. The company says international ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results